| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications.
Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications.
Beauregard ER, Maguire EG.
Ment Health Clin. 2024 Apr 1;14(2):102–6. doi: 10.9740/mhc.2024.04.102. PMCID: PMC11058323.